ArticleOncology nursing forum2025
The Effect of Chemotherapy-Induced Alopecia on Distress and Quality of Life in Male Patients With Cancer.
Article in Oncology nursing forum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Transient p53/p21 activation selectively protects healthy human hair follicles and their stem cells from chemotherapy.The Journal of clinical investigation · 2026Article
- Stingless bee propolis promotes hair follicle regeneration and melanocyte function in chemotherapy-induced alopecia mouse model.Experimental animals · 2026Article
- Scalp cooling therapy in chemotherapy-induced alopecia: addressing variability in cooling duration and efficacy.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate the effects of chemotherapy-induced alopecia (CIA) on the distress and quality of life of male patients with cancer and to identify characteristics that place these patients at risk for higher distress and lower quality of life. PARTICIPANTS &
setting146 patients with alopecia seen in an outpatient chemotherapy unit and receiving at least one cycle of chemotherapy participated in the study from March to December 2023. METHODOLOGIC APPROACH: Data were collected via face-to-face interviews using an individual information form, the National Comprehensive Cancer Network Distress Thermometer, and the CIA Quality-of-Life Scale.
findingsEducation level, marital status, pretreatment hair loss status, alopecia severity, hair accessory use because of alopecia, self-reported mood change from alopecia, and distress score significantly affected CIA and explained 72% of the variance in CIA Quality-of-Life Scale scores. IMPLICATIONS FOR NURSING: Oncology nurses are pivotal in the prevention and early management of CIA. Patients who are expected to lose their hair because of chemotherapy should be informed before treatment and given suggestions to mitigate the impact of changes in appearance. Patients should be educated about pharmacologic and nonpharmacologic approaches that can be used to cope with CIA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.